Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(2)
•••
Comment by bikkel78on Dec 20, 2018 3:32pm
79 Views
Post# 29142665

RE:RE:RE:RE:RE:RE:Here we go again on low volume...

RE:RE:RE:RE:RE:RE:Here we go again on low volume...

all the issues you mentioned = investing in biotech!

Test results, getting money on board etc...

So when it comes to investing in biotech, I look for a strong board, a strong product, insider buying and big potential. IMV has all those cards! I spoke with Fred numerous times and he told me they can get a deal whenever they wanted. But in order to maximize, they wanted to keep the rights. Now that DPX is even better than Keytruda...so it seems from the data, they have a stronger position in future negotiations. 

INvesting in biotech is a bumpy ride, but I see IMV as the new Loxo

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities